Filing Details
Jade Biosciences, Inc. (NASDAQ:JBIO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:JBIO
Jade Biosciences, Inc. (JBIO) Files Quarterly Report for Q0
Jade Biosciences, Inc. (NASDAQ:JBIO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
At publication ·
What changed
Jade Biosciences, Inc. (NASDAQ:JBIO) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Jade Biosciences, Inc. (NASDAQ: JBIO) filed its quarterly report (Form 10-Q) with the SEC on August 10, 2026.
- The company's stock trades at $21.73 with a market capitalization of $484.2 million.
- The 10-Q filing contains unaudited financial statements and management commentary on recent performance, including updated risk factors and changes in business conditions.
Market Context
Jade Biosciences, Inc.'s stock currently trades at $21.73 with a market capitalization of $484.2M.
The 10-Q provides Jade Biosciences, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Jade Biosciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View JBIO Stock Page
Frequently Asked Questions
Where can I read JBIO's SEC filings?
Browse all filings on our JBIO SEC filings page.
What types of SEC filings does Jade Biosciences, Inc. file?
Public companies like Jade Biosciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.